RSRichard John Stevens

Richard John Stevens

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Richard John Stevens has a total of 262 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Benefits and harms of antihypertensive treatment a modelling study in 5.5 million electronic health records

    by Ariel Wang, Constantinos Koshiaris, Niamh Gould, Lucinda Archer, Amitava Banerjee, Brandon K. Bellows, Christopher E. Clark, Andrew Clegg, F. D. Richard Hobbs, Jonathan Mant, et al.

    Antihypertensive prescription is guided by cardiovascular risk prediction models. However, existing models often exclude individuals with prior cardiovascular disease or those prescribed statin treatment. Consequently, there is limited evidence regarding how the benefits and harms of treatment vary according to an individual’s baseline risk. This cohort study includes 5,578,002 patients aged≥40years (mean age 59; 52% women) from the Clinical Practice Research Datalink between 1998–2018. A cardiovascular risk prediction model is developed using the Clinical Practice Research Datalink GOLD dataset and externally validated using the Aurum dataset. The model demonstrates excellent calibration and discrimination. Antihypertensive therapy is more likely to prevent serious major cardiovascular events (eight events prevented per 1,000 patients over 10 years, 95% confidence interval = 1 to 14), than to cause serious falls (two events per 1,000 patients, 95% confidence interval = −4 to 10). The risks of other adverse events indicate more nuanced or potentially harmful trade-offs. Here we show that a cardiovascular risk prediction model developed using routinely collected primary care data accurately predicts risk across a broad population of patients eligible for antihypertensive treatment. These findings will enable clinicians to better communicate individualised benefits and risks of antihypertensive therapy.

  • Open Access

    Measurement error adjusted prevalence of undiagnosed hypertension in England: A cross-sectional study

    by Alejandra Castanon, Andrew Hughes, Katja Grasic, Martin White, James P. Sheppard, Richard J. McManus, Jonathan Pearson-Stuttard, Richard Stevens

    Background: Hypertension case-finding and management is key to reducing premature morbidity and mortality. In England, 14.8% of people receive treatment for hypertension but the total number of hypertensive individuals remains unclear, as it can only be estimated statistically. This study aimed to estimate how many individuals aged 40 + may unknowingly have hypertension by accounting for differences between clinic and out-of-office blood pressure readings. Methods: We analysed individual-level data from the 2017–2019 Health Survey for England (HSE), including individuals aged ≥40 without a hypertension diagnosis. A validated algorithm (Predicting Out-of-Office Blood Pressure- PROOF-BP) was applied to estimate likely out-of-office measurements. Observed BP was defined as the mean of the second and third measurement taken at an HSE visit. Predicted hypertension was calculated using PROOF-BP and observed hypertension using actual clinic measurements. We explored a diagnostic threshold for predicted (out-of-office) hypertension of ≥135/85 mmHg (primary outcome) and of ≥140/90 mmHg (secondary outcome). Weighted hypertension prevalence estimates are presented by age, sex and geographical region. National population statistics were used to extrapolate results to the English population. Results: The observed prevalence of undiagnosed hypertension in the study population was 27.7% (95% Confidence Interval [CI]:26.4%−29.1%). The predicted prevalence after adjustment was 21.8% (95%CI:20.6%−23.0%). Predicted prevalence was nearly double in males (29.8%, 95%CI:27.8%−32.0%) compared to females (14.6%, 95%CI:13.3%−15.9%) and varied by region: West Midlands (26.3%, 95%CI:22.2%−31.0%), London (16.9%, 95%CI:13.5%−20.9%). Extrapolating estimates to the total population aged ≥40 in England we estimate approximately 4.2 million people in England are unaware of their hypertension. Of these we estimate that over 2.9 million could be newly diagnosed by the current diagnostic pathway. Conclusions: Over 4 million people in England are estimated to have undiagnosed hypertension. This study’s refined analytical approach provides a more precise estimate of this population, supporting targeted public health initiatives to identify and address undiagnosed cases.

  • Open Access

    Approach to some data preparation problems in systematic review and meta-analysis

    by Richard J. Stevens, Francesca Little

    In systematic review, the measures reported by the primary studies may not always be the measures sought by the systematic review investigators. Motivated by an systematic review of interventions to reduce meat consumption, we discuss here methods to infer relative risks and confidence intervals from randomized controlled trials that reported differences, possibly in the presence of repeated measures or multiple interventions.

  • Open Access

    The applicability to systematic reviews of common effect, random effects and fixed effects approaches to meta-analysis

    by Richard J Stevens

    Systematic reviewers planning quantitative meta-analysis usually choose between fixed effect meta-analysis, and random effects meta-analysis. An alternative method is called fixed effects (note the s in the name). This method has the unique property that the target estimand is defined by the variances of the studies found by the systematic review. This article considers each in relation to the quantitative analysis of data to be obtained by systematic review. For clarity, I refer to the traditional fixed effect method as the common effect method and the newer approach as fixed effects (plural). Case studies illustrate the post hoc nature of the fixed effects (plural) method, in which the population under study is determined by the data rather than by the protocol. Mathematical analysis shows that unlike common effect and random effects methods, the fixed effects (plural) method requires an additional, and unrealistic, assumption about the data obtained in systematic reviews. A simulation study demonstrates that confidence intervals from fixed effects (plural) meta-analysis do not account for the post hoc nature of the method. Fixed effects (plural) meta-analysis is neither a slot-in replacement for the common effect method nor for the random effects method of meta-analysis. Of the three methods considered here, the common effect method and the random effects method are potentially valid for the quantitative analysis of systematic reviews.

  • Open Access

    Effect of the English National Enhanced Service on weight management referral rate: an interrupted time-series analysis

    by Stella J P Haffner, Richard John Stevens, Ben Amies-Cull, Laura Heath, Clare Bankhead, Paul Aveyard, Susan A Jebb

    Objectives To assess the impact of a National Enhanced Service (NES) incentive for weight management that financially rewarded practices for each eligible patient referred to a weight management programme. Design Interrupted time-series analysis to examine the rate of weight management referral and weight management advice. Setting Primary healthcare records from January 2018 to December 2024 in the Oxford Clinical Informatics Digital Hub, covering 8.3 million patients in 1198 primary care clinics around England. Interventions NES payments to practices for weight management were introduced in April 2021. Results The rate of referral increased from 1 referral per 1000 patients per month before the incentive to around 4 referrals per 1000 patients per month afterwards. There was no evidence that the increase differed by age, gender, ethnic group or socioeconomic status. The occurrence of weight management advice was unchanged by the introduction of the NES and was at least three times more common than referral to weight management services. Conclusions The NES was associated with a fourfold increase in referrals to weight management services. However, clinicians are much more likely to offer advice rather than a referral to a weight management programme. There is a clear opportunity to improve outcomes for patients by encouraging greater use of referrals to effective weight management services in place of advice.


  • Open Access

    Optimising the monitoring and management of raised blood pressure including proteinuria testing during pregnancy: the BUMP research programme including 2 RCTs

    by Richard J McManus, Lucy C Chappell, Katherine L Tucker, Lisa Hinton, Oliver Rivero-Arias, Julie Allen, Rebecca Band, Helen E Campbell, Alison Chisholm, Marcus Green, et al.

    Background: Raised blood pressure affects 10% of pregnancies worldwide, of which around half develop pre-eclampsia including proteinuria, causing maternal and perinatal morbidity and mortality. Objectives: To develop and test interventions for self-monitoring of blood pressure designed to improve the detection and management of hypertension in pregnancy. Additionally, to test the accuracy of self-testing of urine for protein, a key marker of pre-eclampsia. Design and methods: Development phase, a pilot trial, two large randomised controlled trials of self-monitoring of blood pressure interventions with integrated economic evaluations, linked qualitative work, a large survey and a diagnostic accuracy study of self-testing for proteinuria, and finally economic modelling. Setting and participants: Antenatal clinics in 16 English hospitals. Participants were pregnant women and antenatal healthcare professionals. Patient and public involvement: Comprehensive involvement from initial development through to dissemination, with collaboration from both individuals and relevant charities and organisations. Interventions: Self-monitoring of blood pressure supported by app to improve the detection (BUMP1) and management (BUMP2) of raised blood pressure in pregnancy (WS3.2.1 and 2). Proteinuria self-testing by pregnant hypertensive women (UDIP, WS4). Main outcome measures: Qualitative data informed the development of the BUMP App and trial (WS1). Feasibility of self-monitoring of blood pressure in hypertensive pregnancy (recruitment, retention, adherence and intervention persistence) (WS2). Prevalence of self-monitoring of blood pressure during pregnancy (WS3.1). Time to diagnosis of hypertension defined in routinely recorded clinical data (BUMP1, WS3.2.1) and difference in mean systolic blood pressure recorded by healthcare professionals between randomisation and birth (BUMP2, WS3.2.2). WS3.3 and 4.2 evaluated experiences with the trial and UDIP respectively using inductive and deductive thematic analysis. Within-trial cost–consequence analysis and long-term cost-effectiveness modelling (WS3.4 and WS5). Proteinuria testing accuracy (WS4.1). Results: WS1 : Areas important to staff included providing clear patient information and supporting them in decision-making in the context of discrepant readings. The intervention was optimised iteratively with pregnant women. WS2 : A feasibility trial showed that the self-monitoring of blood pressure intervention was feasible and acceptable. WS3.1 : Data from a survey of 5181 women showed that 19% of pregnant women were currently self-monitoring blood pressure but only 482/983 (49%) shared this information with healthcare professionals. WS3.2.1 : Self-monitoring of blood pressure in addition to usual care did not lead to an earlier diagnosis of clinic hypertension in routinely recorded clinical data with no evidence of differences in maternal or perinatal outcomes or serious adverse events (BUMP1). WS3.2.2: Self-monitoring of blood pressure in pregnancy hypertension did not improve clinic blood pressure control, with no difference in maternal or perinatal outcomes or serious adverse events (BUMP2). WS3.3: Self-monitoring was generally accepted by women and professionals with differences in views of which blood pressure data to give precedence. Women found self-monitoring empowering, provided health professionals considered home readings in their management. On occasion self-monitoring proved unsettling due to uncertainty. WS3.4: Within trial economic analyses revealed no significant difference in overall total costs between trial arms in either BUMP1 or BUMP2. Women’s health-related quality of life (EQ-5D-5L) was similar between groups in both trials. WS4 : Self-testing for proteinuria had a sensitivity of 0.71 (95% confidence interval 0.62 to 0.79) and a specificity of 0.89 (95% confidence interval 0.84 to 0.92) compared to laboratory protein–creatinine ratio testing and this was not clinically or statistically different when compared to healthcare professionals or a colorimetric monitor (UDIP, WS4.1). Self-testing was generally acceptable (WS4.2). WS5 : Model frameworks capable of facilitating exploration of the long-term cost-effectiveness of combining self-monitoring of blood pressure with blood pressure treatment and management policies were developed for use in future research projects in the area. Implementation : Self-monitoring was rapidly and widely implemented during the pandemic but has yet to become fully embedded in clinical pathways. Limitations: Self-monitoring of blood pressure by women in the control groups; difficulties in testing self-monitoring of blood pressure in clinical pathways in the absence of evidence or accepted treatment thresholds; process evaluation suggested women and professionals privileged different information. Conclusions: Self-monitoring of blood pressure during higher risk or hypertensive pregnancy was feasible, acceptable, safe, and no more expensive, but did not improve the detection of hypertension or blood pressure control in those with hypertension when used alongside usual care. During the programme, self-monitoring of blood pressure entered common practice in pregnancy, a process accelerated by the pandemic. Pregnant women can read a dipstick for urinary protein with similar accuracy to healthcare professionals or colorimetric testing, and find this acceptable, suggesting that self-testing could be included in clinical pathways. Future work: Future trials of interventions including self-monitoring of blood pressure should test strategies in the context of novel clinical pathways. Study registration: This study is registered as Current Controlled Trials ISRCTN16018898. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Programme Grants for Applied Research programme (NIHR award ref.: RP-PG-0614-20005) and is published in full in Programme Grants for Applied Research ; Vol. 14, No. 3. See the NIHR Funding and Awards website for further award information.

  • Open Access

    Predicting hypotension, syncope, and fracture risk in patients indicated for antihypertensive treatment: the STRATIFY models

    by Constantinos Koshiaris, Ariel Wang, Lucinda Archer, Richard D. Riley, Kym Ie Snell, Richard J. Stevens, Amitava Banerjee, Subhashisa Swain, Andrew Clegg, Christopher E. Clark, et al.

    Antihypertensives are associated with increased risk of syncope, hypotension, and fractures, but the highest-risk individuals are unclear. This study aimed to develop and validate three models to predict these outcomes in patients with an indication for antihypertensive treatment. A cohort study was conducted using data from Clinical Practice Research Datalink (CPRD). Patients aged 40+ with systolic blood pressure 130-179 mmHg were included. Outcomes were first hypotension, syncope, or fracture leading to hospitalization or death within 10 years. Models were derived from CPRD GOLD data ( n = 1,773,224) and validated with CPRD Aurum data ( n = 3,805,366). Each model had 31-37 predictors. Validation demonstrated strong discriminative ability (10-year C-statistic: hypotension 0.824; syncope 0.819; fracture 0.790), with close agreement between predicted and observed risks for the hypotension and syncope models. Some underprediction was observed for the fracture model. These models could be used to help reassure patients about the relatively low risk of harm from antihypertensive treatment, or identify the small number of individuals with a higher risk where additional monitoring may be indicated.


  • Open Access

    The Effect of Weight Loss Before In Vitro Fertilization on Reproductive Outcomes in Women With Obesity

    by Moscho Michalopoulou, Susan Ann Jebb, Alice Hobson, Shen Chuen Khaw, Richard Stevens, Pedro Melo, Stella Jane Pierce Haffner, Kathryn Sheridan Clay, Sarah Mounsey, Ingrid Granne, et al.

    It is unclear whether weight loss before in vitro fertilization (IVF) improves reproductive outcomes in women with obesity. To assess whether weight loss interventions before IVF improve reproductive outcomes. Five electronic databases through 27 May 2025. Randomized controlled trials (RCTs) in women with obesity who were offered a weight loss intervention before planned IVF. Dual independent screening, data extraction, and assessment of risk of bias (RoB) and certainty of evidence. Primary outcomes were pregnancy and live birth rates. Where appropriate, studies were pooled using random-effects meta-analyses. Twelve RCTs (1921 randomly assigned participants) were included, 7 of which had high RoB. There was moderate certainty that pre-IVF weight loss interventions were associated with an increase in total pregnancy rates (risk ratio [RR], 1.21 [95% CI, 1.02 to 1.44]; 11 studies) and pregnancies resulting from unassisted conception (RR, 1.47 [CI, 1.26 to 1.73]; 10 studies), whereas the effect on pregnancies resulting solely from IVF was uncertain. Weight loss interventions were not associated with pregnancy loss rates (RR, 1.05 [CI, 0.98 to 1.13]; 8 studies; moderate certainty), but their effect on live birth rates was unclear (RR, 1.15 [CI, 0.95 to 1.40]; 9 studies; very low certainty). Studies were small, had high RoB, and often did not report important outcomes, such as live births. Substantial clinical and methodological heterogeneity was unexplained by exploratory analyses. Weight loss interventions before IVF appear to increase the chances of pregnancy, especially unassisted conceptions. However, studies were small, and heterogeneity made it difficult to determine the benefit of any particular intervention. National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley. (PROSPERO: CRD42023441457).


  • Open Access

    Global Blood Pressure Screening During and After Pregnancy: May Measurement Month 2019

    by Liza Bowen, Richard J. Stevens, Aletta E. Schutte, Thomas Beaney, Neil R. Poulter, Richard J. McManus, Lucy C. Chappell

    BACKGROUND: Hypertensive disorders of pregnancy are associated with high maternal and fetal morbidity and mortality. There are limited global data on the characteristics of women during and after pregnancy hypertension. METHODS: May Measurement Month is a global campaign to raise awareness of the importance of blood pressure. Adults (≥18 years) recruited through opportunistic sampling during May 2019 had blood pressure measured and comorbidities and lifestyle data collected. This secondary analysis included 16 519 pregnant women and 529 172 nonpregnant women (16 457 with previous raised blood pressure in pregnancy) from 64 countries. RESULTS: Almost half of the pregnant women (43.3%) reported not having had their blood pressure measured in the past year, and 14.3% (95% CI, 12.1–16.6) had hypertension (blood pressure ≥140/90 mm Hg or taking antihypertensive medication). Diabetes was self-reported in 7.6% (5.9–9.3) of pregnant women with hypertension and 2.8% (1.9–3.6) of pregnant women without hypertension. In nonpregnant women with and without a history of pregnancy hypertension, age-standardized proportions with current hypertension were 53.2% (50.8–55.7) versus 33.3% (29.3–37.3); with diabetes were 14.4% (11.8–17.0) versus 8.5% (6.3–10.9); and with body mass index ≥30 kg/m 2 were 28.4% (23.5–33.3) versus 16.6% (13.0–20.2). CONCLUSIONS: Hypertension in pregnancy was common in this global sample but many cases had not previously been identified. There was a clustering of cardiovascular risk factors in both pregnant women with current hypertension and previously raised blood pressure in pregnancy. This work highlights the importance of screening pregnant women for hypertension, which remains a challenge in large parts of the world.


  • Open Access

    Strategies to improve the implementation of preventive care in primary care: a systematic review and meta-analysis

    by Laura Heath, Richard Stevens, Brian D. Nicholson, Joseph Wherton, Min Gao, Caitriona Callan, Simona Haasova, Paul Aveyard

    Background: Action on smoking, obesity, excess alcohol, and physical inactivity in primary care is effective and cost-effective, but implementation is low. The aim was to examine the effectiveness of strategies to increase the implementation of preventive healthcare in primary care. Methods: CINAHL, CENTRAL, The Cochrane Database of Systematic Reviews, Dissertations & Theses – Global, Embase, Europe PMC, MEDLINE and PsycINFO were searched from inception through 5 October 2023 with no date of publication or language limits. Randomised trials, non-randomised trials, controlled before-after studies and interrupted time series studies comparing implementation strategies (team changes; changes to the electronic patient registry; facilitated relay of information; continuous quality improvement; clinician education; clinical reminders; financial incentives or multicomponent interventions) to usual care were included. Two reviewers screened studies, extracted data, and assessed bias with an adapted Cochrane risk of bias tool for Effective Practice and Organisation of Care reviews. Meta-analysis was conducted with random-effects models. Narrative synthesis was conducted where meta-analysis was not possible. Outcome measures included process and behavioural outcomes at the closest point to 12 months for each implementation strategy. Results: Eighty-five studies were included comprising of 4,210,946 participants from 3713 clusters in 71 cluster trials, 6748 participants in 5 randomised trials, 5,966,552 participants in 8 interrupted time series, and 176,061 participants in 1 controlled before after study. There was evidence that clinical reminders (OR 3.46; 95% CI 1.72–6.96; I2 = 89.4%), clinician education (OR 1.89; 95% CI 1.46–2.46; I2 = 80.6%), facilitated relay of information (OR 1.95, 95% CI 1.10–3.46, I2 = 88.2%), and multicomponent interventions (OR 3.10; 95% CI 1.60–5.99, I2 = 96.1%) increased processes of care. Multicomponent intervention results were robust to sensitivity analysis. There was no evidence that other implementation strategies affected processes of care or that any of the implementation strategies improved behavioural outcomes. No studies reported on interventions specifically designed for remote consultations. Limitations included high statistical heterogeneity and many studies did not account for clustering. Conclusions: Multicomponent interventions may be the most effective implementation strategy. There was no evidence that implementation interventions improved behavioural outcomes. Trial registration: PROSPERO CRD42022350912.